Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

China Vaccine Scandal: Hundreds Demoted But Root Causes Remain

This article was originally published in PharmAsia News

Executive Summary

In a high-profile gesture of showing no tolerance towards poor product quality and management, China has arrested over 200 and punished 357 officials, but root cause of the scandal is much harder to root out in a short term, observers say.

Advertisement

Related Content

Sanofi Upbeat On China Growth, Investment Despite Q4 Weakness
2016 Review: Rapid Change Defines China Regulatory Environment
China Growth Rebounds But Pharma Starts Cutting Prices
Sanofi’s Emerging Markets Steady Despite Venezuela Volatility
WHO’s Chan Outlines ‘Chinese Dream’ For Health Care Reforms

Topics

Advertisement
UsernamePublicRestriction

Register

SC089432

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel